BVS logo

BVS
Bioventus Inc - Ordinary Shares - Class A

436
Mkt Cap
$756.71M
Volume
324,096.00
52W High
$9.53
52W Low
$5.81
PE Ratio
27.65
BVS Fundamentals
Price
$9.06
Prev Close
$9.10
Open
$9.08
50D MA
$8.68
Beta
1.12
Avg. Volume
488,318.94
EPS (Annual)
$0.3299
P/B
3.30
Rev/Employee
$610,846.24
$817.18
Loading...
Loading...
News
all
press releases
Bioventus Inc. (NASDAQ:BVS) Given Consensus Rating of "Buy" by Brokerages
Shares of Bioventus Inc. (NASDAQ:BVS - Get Free Report) have received an average rating of "Buy" from the five ratings firms that are covering the stock, Marketbeat Ratings reports. One equities...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
CJS Securities Initiates Coverage on Bioventus (NASDAQ:BVS)
CJS Securities started coverage on Bioventus in a research note on Friday. They issued an "outperform" rating and a $14.00 target price on the stock...
MarketBeat·15d ago
News Placeholder
Divisadero Street Capital Management LP Sells 385,116 Shares of Bioventus Inc. $BVS
Divisadero Street Capital Management LP lessened its position in Bioventus Inc. (NASDAQ:BVS - Free Report) by 35.6% in the third quarter, according to the company in its most recent filing with the...
MarketBeat·26d ago
News Placeholder
Michelle Mcmurry-Heath Sells 12,000 Shares of Bioventus (NASDAQ:BVS) Stock
Bioventus Inc. (NASDAQ:BVS - Get Free Report) Director Michelle Mcmurry-Heath sold 12,000 shares of the company's stock in a transaction on Wednesday, March 11th. The stock was sold at an average...
MarketBeat·28d ago
News Placeholder
Bioventus (NASDAQ:BVS) Director Michelle Mcmurry-Heath Sells 12,000 Shares
Bioventus Inc. (NASDAQ:BVS - Get Free Report) Director Michelle Mcmurry-Heath sold 12,000 shares of the business's stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at...
MarketBeat·28d ago
News Placeholder
Bioventus Inc. (NASDAQ:BVS) Receives Consensus Recommendation of "Buy" from Analysts
Shares of Bioventus Inc. (NASDAQ:BVS - Get Free Report) have received an average recommendation of "Buy" from the five research firms that are currently covering the firm, Marketbeat reports. One...
MarketBeat·29d ago
News Placeholder
Bioventus (NYSE:BVS) Stock Price Expected to Rise, Barrington Research Analyst Says
Barrington Research lifted their target price on Bioventus from $13.00 to $14.00 and gave the stock an "outperform" rating in a research report on Friday...
MarketBeat·1mo ago
News Placeholder
Bioventus (NYSE:BVS) Given New $16.00 Price Target at Craig Hallum
Craig Hallum upped their target price on Bioventus from $15.00 to $16.00 and gave the stock a "buy" rating in a research note on Friday...
MarketBeat·1mo ago
News Placeholder
Bioventus (NASDAQ:BVS) Shares Down 8.2% - Here's Why
Bioventus (NASDAQ:BVS) Stock Price Down 8.2% - Here's What Happened...
MarketBeat·1mo ago
News Placeholder
Bioventus Q4 Earnings Call Highlights
Bioventus (NASDAQ:BVS) executives told investors the company closed 2025 with what leadership described as a solid quarter and a pivotal year, highlighting stronger organic growth, higher...
MarketBeat·1mo ago
<
1
2
...
>

Latest BVS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.